DVNHF yields 17421.60% · PFE yields 6.13%● Live data
📍 DVNHF pulled ahead of the other in Year 1
Combined, DVNHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DVNHF + PFE for your $10,000?
Frontier Services Group Limited, an investment holding company, provides aviation, logistics, security, insurance, and infrastructure related services. The company operates through Aviation and Logistics Business; Security, Insurance and Infrastructure Business; and Financial Market Information Business segments. It offers online financial market information. The company's security services include protective services and specialized training services; logistics services comprise engineering project logistics services and special logistics services, such as transportation of valuables; and infrastructure solutions include project planning, business consulting, investment and financing, engineering design, project implementation and operation, and support services. It also provides consultancy and freight forwarding services; finance, liability, property, and personnel insurance services; and healthcare and airport management services. The company serves the oil and gas, mining, finance, energy, and infrastructure industries, as well as organizations. It operates in Africa, Europe, the People's Republic of China, Mainland China, Hong Kong, southeast Asia, and the Middle East. The company was formerly known as DVN (Holdings) Limited and changed its name to Frontier Services Group Limited in March 2014. Frontier Services Group Limited is headquartered in Admiralty, Hong Kong.
Full DVNHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.